Contact this trialFirst, we need to learn more about you.
SGLT2 Inhibitor
Empagliflozin for Type 2 Diabetes
Recruiting0 awardsPhase < 1
San Antonio, Texas
This trial tests a diabetes drug's effect on glucose and fat metabolism, and norepinephrine levels in people with type 2 diabetes.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.